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ABSTRACT
Objective NFκB is the key modulator in inflammatory 
disorders. However, the key regulators that activate, 
fine- tune or shut off NFκB activity in inflammatory 
conditions are poorly understood. In this study, we aim 
to investigate the roles that NFκB- specific long non- 
coding RNAs (lncRNAs) play in regulating inflammatory 
networks.
Design Using the first genetic- screen to identify 
NFκB- specific lncRNAs, we performed RNA- seq from the 
p65-/- and Ikkβ-/- mouse embryonic fibroblasts and report 
the identification of an evolutionary conserved lncRNA 
designated mNAIL (mice) or hNAIL (human). hNAIL is 
upregulated in human inflammatory disorders, including 
UC. We generated mNAILΔNFκB mice, wherein deletion 
of two NFκB sites in the proximal promoter of mNAIL 
abolishes its induction, to study its function in colitis.
Results NAIL regulates inflammation via sequestering 
and inactivating Wip1, a known negative regulator of 
proinflammatory p38 kinase and NFκB subunit p65. 
Wip1 inactivation leads to coordinated activation of 
p38 and covalent modifications of NFκB, essential for 
its genome- wide occupancy on specific targets. NAIL 
enables an orchestrated response for p38 and NFκB 
coactivation that leads to differentiation of precursor 
cells into immature myeloid cells in bone marrow, 
recruitment of macrophages to inflamed area and 
expression of inflammatory genes in colitis.
Conclusion NAIL directly regulates initiation and 
progression of colitis and its expression is highly 
correlated with NFκB activity which makes it a perfect 
candidate to serve as a biomarker and a therapeutic 
target for IBD and other inflammation- associated 
diseases.
INTRODUCTION
Chronic inflammatory diseases such as IBD stem 
from dysregulated immune responses, aberrant 
cytokine/chemokine secretion and alterations in 
intestinal barrier and microbiota.1 In IBD, intes-
tinal microbiota releases enterotoxins that increase 
the permeability of intestinal mucosa, resulting in 
a state of intestinal inflammation caused by inva-
sion of harmful bacteria and damaged intestinal 
epithelial cells.2 In UC patients, NFκB is activated 
in epithelial cells and mucosal macrophages that 
enhances the secretion of a broad panel of NFκB- 
regulated cytokines including TNFα, IL-1 and 
IL-6.3 Due to recurrent cycles of evoked inflamma-
tory activation, IBD patients have been shown to be 
more susceptible to cytokine storm syndrome4 and 
cancer development. This is due to the hyperactive 
NFκB- dependent cytokine secretion which induces 
Significance of this study
What is already known on this subject?
 ► NFκB is highly activated in IBD patients and 
associated with disease severity.
 ► NFκB and p38 have been shown to be required 
for the expression of proinflammatory genes for 
full- blown inflammation.
 ► NFκB activity can be shut off by 
dephosphorylation of active p65 by the Wip1 
phosphatase leading to loss of its chromatin 
remodelling potential and consequently 
reduced transcription of NFκB targets.
 ► A number of signalling regulators, including 
enzymes, adaptor proteins and non- coding 
RNAs such as miRNAs which regulate NFκB 
and p38 have been identified and characterised.
 ► Several lncRNAs have been proposed to be 
induced on TNFα stimulation and dysregulated 
in human inflammatory diseases.
 ► lncRNAs can interact with kinases and regulate 
their activity.
What are the new findings?
 ► NAIL is the first lncRNA to be identified by a 
genetic screen, and its expression is absolutely 
NFκB dependent. This autoregulation is unique 
and not documented before.
 ► NAIL forms a positive feedback loop with NFκB 
signalling, and its expression is enhanced in 
colitis.
 ► NAIL regulates the development of colitis by 
regulating the expression of inflammatory 
cytokines and recruitment of effector cells to 
the site of inflammation.
 ► NAIL simultaneously activates p38, a kinase 
and p65 a transcription factor. Such direct 
coordinated activation of two pathways has not 
been documented for any other lncRNA.
 ► NAIL deactivates a phosphatase (Wip1) 
essential to activate NFκB and p38 signalling 
for full- blown inflammation in colitis.
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hyper proliferation of immune cells and excessive tissue damage, 
resulting in an accumulation of new cancer mutations.5 6
There are many regulators of NFκB, including kinases, ubiq-
uitin ligases and miRNAs. Some of these have been identified 
as potential therapeutic targets.7 However, only ~1%–2% of 
the human genome encodes proteins, while 75%–90% is tran-
scribed into non- coding RNAs;8 it is plausible that the key regu-
lators that activate, fine- tune or shut off NFκB activity have yet 
to be discovered. Long non- coding RNAs (lncRNAs) constitute 
the majority of this rampant transcription of the mammalian 
genome.8 9
To identify lncRNAs that are directly and specifically regu-
lated by NFκB, we performed RNA- seq from wild type (WT), 
p65-/- and Ikkβ-/- mouse embryonic fibroblasts (MEFs) treated 
with TNFα for different time points (figure 1A,B). This screen 
revealed a novel, evolutionarily conserved lncRNA, Gm16685 in 
mouse and its human homolog (loc105375914), both of which 
are prominently and specifically activated by the p65 subunit of 
NFκB. We named this unannotated lncRNA as NFκB Associ-
ated Immunoregulatory Long non- coding RNA, NAIL. hNAIL 
is upregulated in many human inflammatory disorders including 
UC. To model NAIL’s function, we deleted the two conserved 
NFκB sites in the proximal mouse NAIL (mNAIL) promoter and 
generated a mouse model (mNAILΔNFκB) in which NAIL gene is 
unresponsive to NFκB- dependent activation. mNAILΔNFκB mice 
displayed decreased expression of NFκB targets and conse-
quently had reduced colitis. On inflammatory stimulation, NAIL 
is expressed, and sequester Wip1 phosphatase and prevent Wip1 
from dephosphorylating, and deactivating active p65 and other 
Wip1 targets such as p38 necessary for full- blown inflammatory 
gene expression. These results provide the first evidence that 
lncRNAs can directly modulate phosphatase accessibility to its 
substrates which has important consequences in inflammation.
RESULTS
Identification and characterisation of Gm16685 (mNAIL); a 
novel lncRNA specifically regulated by NFκB signaling
Besides activating the NFκB pathway, TNFα receptor engage-
ment also leads to activation of JNK, p38 and apoptotic path-
ways (figure 1A). Since NFκB activation is specifically impaired 
in p65-/- and Ikkβ-/- MEFs (online supplemental figure 1A,B) 
downstream of TNF signalling, we employed these cells to iden-
tify NFκB- driven lncRNAs. Differentially expressed lncRNAs 
between WT, p65-/- and Ikkβ-/- MEFs on TNFα stimulation were 
identified (figure 1B). To identify lncRNAs that were directly 
and specifically regulated by NFκB signalling, we selected the 
lncRNAs that were TNFα inducible in a time- dependent manner 
in WT but not in p65-/- and Ikkβ-/- MEFs. We selected Gm16685, 
a novel lncRNA expressed in the antisense direction of inter-
leukin-7 (IL7), for further functional and mechanistic studies 
(figure 1C). Gm16685 expression was dramatically upregulated 
in WT MEFs stimulated with TNFα (figure 1D). However, 
compared with WT MEFs, Gm16685 expression in p65-/-, Ikkβ-
/- and Ikkγ-/- immortalised MEFs was significantly dampened on 
TNFα stimulation (online supplemental figure 1C,D). Primary 
MEFs derived from WT, p65-/- and Ikkβ-/- mice also showed 
that activation of Gm16685 occurred specifically in an Ikkβ-de-
pendent and p65- dependent manner (figure 1E). Gm16685 
expression was also induced by stimulation with TLR4 ligand, 
lipopolysaccharides (LPS) in WT immortalised MEFs (online 
supplemental figure 1E). Importantly, the antisense gene IL7 
remained relatively unchanged on stimulation (online supple-
mental figure 1F), suggesting the specificity of induction of 
Gm16685 by p65 via Ikkβ. Taken together, these results suggest 
that Gm16685 expression is specifically activated by NFκB 
signalling, downstream of major inflammatory stimuli such as 
TNFα and LPS.
loc105375914 (hNAIL), an evolutionarily conserved human 
homolog of Gm16685 (mNAIL) is upregulated in UC
Determining which lncRNAs are evolutionarily conserved high-
lights the functional importance of such transcripts in funda-
mental biological processes.10 To identify human orthologue 
of Gm16685 (mNAIL), we converted genome coordinates of 
Gm16685 (chr3:7612705–7690001) in mouse (mm10) to 
human (hg38) genome coordinates by using UCSC liftOver with 
default parameters. Human lncRNA, loc105375914 (hNAIL) 
(chr8:78804578–78937681) overlapped with the converted 
region (chr8:78804472–78902467), hence, loc105375914 
was considered as candidate orthologue of mouse Gm16685. 
Although lncRNAs have poor sequence conservation, their 
promoter regions are generally more conserved.11 Hence, 
we performed multiple sequence alignment using promoter 
sequence of the mouse Gm16685 and sequences of 31 other 
species at the same region with reference to UCSC comparative 
genomic track (online supplemental figure 2A). Promoter motifs 
enrichment analysis identified NFκB as the most significantly 
enriched motif across all orthologues (online supplemental 
figure 2B). Most importantly, the RNA binding protein (RBP) 
binding motifs predicted using RBPmap server (http:// rbpmap. 
technion. ac. il/) showed that >80% of RBPs predicted to bind 
Gm16685 are also predicted to bind the human loc105375914 
lncRNA (online supplemental figure 2C) suggesting that hNAIL 
and mNAIL are most likely functionally conserved.
Analyses of publicly available p65 (RelA) ChIP- seq data12 13 
from mouse dendritic cells, macrophages stimulated with LPS 
and human adipocytes and fibroblasts stimulated with TNFα 
demonstrated that p65 binds to the promoter regions of 
Gm16685 and loc105375914 in a stimulus- dependent manner 
(online supplemental figure 2D,E). Additionally, RNA Poly-
merase 2 (Pol2) ChIP- seq data14 15 from these human adipocytes 
and fibroblasts revealed that loc105375914 expression is driven 
by RNA Pol2 in conjunction with NFκB (online supplemental 
figure 2E). Two p65 (RelA) binding motifs located upstream of 
Gm16685 are highly conserved across species, suggesting that 
these motifs might be functionally important for regulation and 
subsequent transcription of Gm16685 across species. Further-
more, NAIL does not have coding potential as shown by compu-
tational analyses (online supplemental figure 2F) and 3’ Flag 
tagging strategy (online supplemental figure 2G).
Hyperactivation of NFκB is a functional determinant in the 
development of inflammatory diseases such as UC that causes 
inflammation in the colonic mucosa.16 Since loc105375914 is 
transcriptionally regulated by NFκB, we analysed transcriptomes 
of 24 inflamed and matched non- inflamed sections from human 
Significance of this study
How might it impact on clinical practice in the foreseeable 
future?
 ► The critical role of NAIL in Wip1- NFκB/p38 axis in the 
development of colitis serves as an attractive target for 
the development of future therapies against inflammatory 
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Figure 1 Identification of lncRNAs regulated by NFκB signalling pathway. (A) NFκB signalling pathway and screening strategy used to identify 
NFκB- regulated lncRNAs. Crosses represent loss of the corresponding proteins (Ikkβ, Ikkγ, p65) using KO MEFs. (B) Heatmap of logCPM values 
of differentially expressed lncRNAs in WT, p65-/- and Ikkβ-/- in immortalised MEFs exposed to TNFα for the indicated time points and analysed 
by paired- end RNA- sequencing. Gm16685 is shown with red arrow. (C) Schematic view of genetic loci of Gm16685 lncRNA (blue). Gm16685 
is expressed from antisense direction to IL7 gene (red). NFκB binding motifs in the promoter region of Gm16685 shown as yellow highlighted 
sequences. (D) RT- qPCR analysis of Gm16685 transcript levels in immortalised WT MEFs exposed to TNFα for different time points as indicated. (E) 
RT- qPCR analysis of Gm16685 in WT (n=5), p65-/- (n=8) and Ikkβ-/- (n=3) independent primary MEFs treated with TNFα for indicated time courses. 
P values were calculated using Student’s t- test method (***p<0.001). (F) Gene expression profile of 24 inflamed and patient match non- inflamed 
samples. Differentially expressed genes are shown in heatmap. LOC105375914 is shown with red arrow. (G) Box plot shows upregulation of hNAIL 
(LOC105375914) expression in inflamed colon tissue of UC patients. KO, knock out; MEFs, mouse embryonic fibroblasts; WT, wild type.
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UC patients. In inflamed colons, we observed dramatic upregu-
lation of NFκB target genes including TNFα and IL1β (figure 1F) 
which are known to be key regulators of intestinal inflamma-
tion.17 As compared with non- inflamed controls, loc105375914 
expression is significantly upregulated in the inflamed colons 
(figure 1G), suggesting that loc105375914 expression highly 
correlates with NFκB activity and may serve as a biomarker for 
IBDs. Collectively, these results indicate that loc105375914 is a 
conserved human homolog of Gm16685, and both their expres-
sions are specifically driven by NFκB signalling in response 
to inflammatory and microbial triggers across species and cell 
types. Hereafter, we will refer to Gm16685 as mNAIL and 
loc105375914 as hNAIL (NFκB Associated Immunoregulatory 
Long non- coding RNA).
mNAILΔNFκB mice display loss of mNAIL activation by NFκB 
and dampened inflammation
We generated mNAILΔNFκB mice wherein two conserved NFκB 
binding motifs upstream of mNAIL were removed using clus-
tered regularly interspaced short palindromic repeats (CRIS-
PR)- Cas9 genome editing (figure 2A). mNAILΔNFκB mice were 
born alive in normal Mendelian ratios and had no overt pheno-
types (figure 2B). Deletion of the NFκB motifs was confirmed by 
genotyping PCR (figure 2C) and Sanger sequencing (figure 2D). 
Three independent mNAILWT and mNAILΔNFκB primary MEF 
clones showed that mNAIL expression was abolished in the 
mNAILΔNFκB clones, whereas the expression level of IL7 gene 
was unaffected on TNFα treatment (figure 2E,F). We also 
observed decreased expression of NFκB targets TNFα and IL1β 
levels on TNFα treatment in mNAILΔNFκB MEFs compared with 
mNAILWT MEFs (figure 2G,H). Depletion of mNAIL by two 
independent siRNAs showed reduced NFκB target gene expres-
sion (figure 2I,J) and significant reduction in phosphorylation 
of p65 and p38 (figure 2K). To exclude the possibility that the 
observed phenotypes might stem from genome editing and its 
off target effects on IL7 or it neighbouring genes, we first anal-
ysed the expression of IL7 across different tissues in mice using 
NCBI fragments per kilobase of exon per million reads (FPKM) 
data. Since IL7 is highly expressed in thymus, spleen and colon 
tissues (online supplemental figure 3A), we analysed its expres-
sion in thymus between mNAILWT and mNAILΔNFκB groups and 
observed no significant difference in RNA and protein levels 
(online supplemental figure 3B,C). Although we did not observe 
any disruption of IL7 expression (RNA and protein level), we 
knocked- down IL7 gene using siRNA to investigate the impact 
of IL7 on NFκB signalling. Depletion of IL7 did not affect NFκB 
activation as judged by expression of TNFα (online supple-
mental figure 3D–F). Taken together, these results suggest that 
editing the two conserved NFκB sites in the NAIL promoter 
specifically dampens inducibility of NAIL in response to inflam-
matory stimuli and that NAIL in turn regulates NFκB targets 
genes in vivo.
mNAILΔNFκB mice display reduced colitis and colon 
inflammation
mNAILΔNFκB mice display reduced colitis and colon inflamma-
tion mNAILWT and mNAILΔNFκB mice were given 3% dextran 
sulfate sodium (DSS) to induce acute colitis (figure 3A). Initial 
body weights of mNAILWT and mNAILΔNFκB mice were similar, 
however, on DSS treatment, mNAILΔNFκB mice displayed less 
severe body weight loss when compared with mNAILWT coun-
terparts (figure 3A). On DSS treatment, colon shortening was 
significantly less pronounced in mNAILΔNFκB mice and the disease 
activity index (DAI) was lower when compared with mNAILWT 
counterparts (figure 3B–D). These results were suggestive of 
reduced inflammation in mNAILΔNFκB mice.
DSS treatment has been shown to alter the myeloid precursor 
population in the bone marrow which directly correlates with the 
degree of inflammation in the colon.18 19 Especially, monocytes 
derived from the CD11b+Ly6ChiLy6G− immature myeloid 
cells have been shown to enter tissues under inflammatory 
conditions and express high levels of proinflammatory cytokines 
in colitis.20–22 Given that myeloid cells are the predominant cells 
that infiltrate the inflamed tissues and the precursors are made in 
bone marrow,23 we analysed the myeloid populations in the bone 
marrow of mNAILΔNFκB mice. As expected, both mNAILWT and 
mNAILΔNFκB mice showed increased CD11b+population, on 
DSS treatment (figure 3E–G). Next, we analysed CD11b posi-
tive subpopulations CD11b+Ly6chi+Ly6g− and CD11b+Ly-
6cLow+Ly6g+ in bone marrow (figure 3F). DSS induced 
increase in Ly6Chi activator cell population was significantly 
more pronounced in mNAILWT mice (figure 3H). Conversely, 
compared with mNAILWT mice, elevated levels of Ly6clowLy6g+-
cells were seen in mNAILΔNFκB mice (figure 3I). To further investi-
gate if NAIL has any role on the stem cell population in the bone 
marrow, we analysed the progenitor cells in the bone marrows 
of mNAILWT and mNAILΔNFκB mice treated with or without 
DSS24 (online supplemental figure 4A). Cells were initially gated 
as LIN- cells and based on the c- KIT and Sca-1 expression, the 
long- term and short- term hemateopoietic stem cell populations 
(KL, KSL and K- low_S- low) were selected. KL cells were further 
gated based on their CD16/32 and CD34 expression to identify 
megakaryocyte–erythrocyte, common myeloid progenitor and 
granulocyte- macrophage progenitors. To identify the common 
lymphoid progenitors population, we further gated K- low_S- low 
cells based on their IL7ra expression. Representative FACS data 
and quantification of all samples (online supplemental figure 
4A–E) are shown for mNAILWT and mNAILΔNFκB mice. No differ-
ence was observed in the stem cells and precursor cells popu-
lation between mNAILWT and mNAILΔNFκB mice suggesting that 
NAIL does not alter the stem cell and progenitor populations. 
Instead, our data suggest that mNAIL is a key determinant for 
the differentiation of precursor cells into CD11b+Ly6 c or Ly6g 
sub- types during inflammation.
mNAIL expression is functionally regulated in bone marrow-
derived macrophages (BMDM)
To identify the major site of mNAIL expression in vivo, we 
dissected the response of mNAIL in different cell types and 
tissues including thymus, liver, spleen, lung and BMDM using 
the systemic LPS- induced endotoxemia model (figure 4A–E). 
We observed mild induction of mNAIL in thymus and liver 
(figure 4A,B) but not in spleen and lung tissues (figure 4C,D). 
Strong induction of mNAIL in BMDMs was observed 
(figure 4E,F). We observed dampened induction of NFκB targets 
TNFα, CCL2 and CXCL2 on LPS challenge in mNAILΔNFκB 
BMDM (figure 4G–J). ChIP- qPCR results showed that the 
absence of mNAIL resulted in dramatic reduction of p65 occu-
pancy at the promoters of these well- known NFκB target genes 
(figure 4K,L) suggesting that loss of NAIL impacts DNA binding 
and hence transcription by NFκB. We observed significant reduc-
tion in phospho- p65 and phospho- p38 levels in the absence of 
mNAIL in the BMDMs (figure 4M). We did not observe any 
change for an irrelevant protein phospho- MKK4 suggesting the 
specificity of NAIL acting on the phosphorylation of p65 and 
p38 (figure 4M). Crucially, myeloid lineage specific knock outs 
by copyright.
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Figure 2 mNAILΔNFκB mice display decreased activation of NFκB and inflammation. (A) Schematic view of mNAIL lncRNA promoter targeting with 
CRISPR- Cas9 editing. NFκB binding motifs are shown in yellow in the promoter region of mNAIL. (B) mNAIL mice were generated using standard 
methods (refer to ‘Materials and methods’ section). mNAIL mice were born in normal Mendelian ratio (table below) and unchallenged mice appear 
normal. (C) Genotyping PCR results of mNAILWT and mNAILΔNFκB mice. PCR products from mNAILWT and mNAILΔNFκB alleles are shown. (D) Sanger 
sequencing results of mNAILWT and mNAILΔNFκB cells. (E–H) mNAILWT and mNAILΔNFκB MEFs (n=3) were treated with TNFα for the indicated time 
points. Expression analysis was performed by RT- qPCR for (E) mNAIL, (F) IL7, (G) TNFα and (H) IL1β genes. (I–K) WT MEFs were transfected with 
si- Control, si- NAIL #1 and si- NAIL #2 siRNAs. After 48 hours post- transfection, cells were treated with or without TNFα and harvested for gene 
expression analysis. Graphs show the gene expression analysis of (I) mNAIL and (J) TNFα by RT- qPCR. Actin was used as a control. Error bars indicate 
mean±SD of three independent experiments. P values were calculated using Student’s t- test method (*p<0.05; **p<0.01; n.s., not significant). (K) 
Cells lysate were analysed with western blot for the indicated proteins. MEFs, mouse embryonic fibroblasts; WT, wild type.
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Figure 3 mNAILΔNFκB mice are resistant to dextran sulfate sodium (DSS)- induced colitis. (A) Scheme of DSS- induced colitis model is shown on the 
top panel. mNAILWT and mNAILΔNFκB mice were treated as shown in top panel. Body weight measurements from mice monitored for 8 days (bottom 
panel). (B and C) Colon length of DSS- treated mNAILWT and mNAILΔNFκB mice measured at day 8. (D) Disease activity index was recorded daily. 
(E) Bone marrow cells were isolated from the DSS- treated mNAILWT and mNAILΔNFκB mice at day 8 and were stained for CD11b (PE), Ly6c (BV711) 
and Ly6g (FITC) cell surface markers. Cells were analysed by FACS and gated as CD11b+cells. Representative FACS data were shown for mNAILWT 
and mNAILΔNFκB mice treated with or without DSS. (F) CD11b+cells were further gated for Ly6c and Ly6g markers. (G–I) Quantification of CD11b+, 
CD11b+Ly6Chi+Ly6G−, CD11b+Ly6Clow+Ly6G+cells gated in (E) and (F). Error bars indicate mean±SD of three independent experiments (UT: n=9, 
DSS: n=15). P values were calculated using Student’s t- test method (*p<0.05; **p<0.01; ***p<0.001; ****p<0.0001; n.s., not significant). DSS, 
dextran sulfate sodium; FACS, fluorescence- activated cell sorting; SSC, side scatter; side scatter; UT, untreated; WT, wild type.
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Figure 4 mNAIL is expressed mainly in myeloid cells and its expression amplifies activation of NFκB and inflammation. (A–E) LPS (5 mg/kg) 
was injected intraperitoneally into C57BL/6N WT mice (n=6). (A) Thymus, (B) liver, (C) spleen and (D) lung tissues were collected after 4 hours and 
expression analysis was performed by RT- qPCR for mNAIL gene. (E, F) Bone marrow cells isolated from WT mice (n=6) and differentiated into bone 
marrow- derived macrophages (BMDM) for 7 days. BMDM cells were treated with or without LPS (200 ng/mL) for 4 hours. (E) Graph shows the mNAIL 
expression analysis by qPCR. (F) Time kinetics of mNAIL expression is shown in LPS- stimulated BMDM cells. Data were normalised to actin. (G–J) 
Bone marrow cells isolated from mNAILWT and mNAILΔNFκB mice (n=6) and differentiated into BMDM for 7 days. BMDM cells were treated with or 
without LPS (200 ng/mL) for 4 hours. Graph shows the gene expression analysis of (G) mNAIL, (H) TNFα, (I) CCL2 and (J) CXCL2 by qPCR. Data were 
normalised to actin. (K–L) mNAILWT and mNAILΔNFκB BMDM cells were treated with or without LPS, and ChIP analysis was performed for p65 (n=3). 
Graph shows the ChIP- qPCR analysis of p65 occupancy on the (K) TNFα and (L) CXCL2 promoters. Error bars indicate mean±SD of three biological 
replicates. P values were calculated using Student’s t- test method (*p<0.05; **p<0.01; ***p<0.001; ****p<0.0001; n.s., not significant). (M) 
Western blot shows the total and phosphorylated p65, p38 and MKK4 in BMDM cells treated with or without LPS. Each replicate is labelled as #1, #2 
and #3. UT, untreated; WT, wild type.
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(KO) of p65 and p38 display reduced inflammatory responses 
and body weight differences in DSS model, highly resembling 
the observations in mNAILΔNFκB mice.23 25 26 To determine the 
molecular basis of this function of NAIL, we performed RNA- 
seq using colon tissues of mNAILWT and mNAILΔNFκB mice with 
or without DSS treatment (figure 5A). Only a few genes were 
differentially expressed in the untreated (UT) group, reiterating 
that the deletion of two NFκB sites in the proximal promoter 
of mNAIL does not cause any global alterations in the tran-
scriptome due to genome editing artefacts (online supple-
mental figure 5). However, DSS treatment caused vast changes 
in gene expression, with a majority of genes down- regulated in 
mNAILΔNFκB mice (figure 5A). Gene ontology analysis revealed 
that the majority of differentially expressed and downregulated 
genes in mNAILΔNFκB colons belong to inflammatory pathways 
regulated by NFκB (online supplemental figure 5B). To validate 
the RNA- seq results, we performed gene expression analysis of 
NFκB target genes and observed reduced expression of TNFα, 
IL1β and CCL2 genes in colon tissues of mNAILΔNFκB mice as 
compared with mNAILWT group (figure 5B–E). Similar to gene 
expression results, TNFα and IL1β protein levels were reduced 
in the colon tissues (figure 5F,G). We also observed reduced 
level of phospho- p65 and phospho- p38 in colons of DSS- treated 
mNAILΔNFκB as compared with mNAILWT group (figure 5H).
Colons from DSS- treated mNAILWT and mNAILΔNFκB mice 
at day 8 were stained with mNAIL- specific fluorescence in situ 
hybridisation (FISH) probe, p- p65 and p- p38 antibodies and 
analysed using confocal microscopy. We only detected basal 
mNAIL expression and did not observe any positive staining 
for p- p65 and p- p38 in the UT colon sections of mNAILWT and 
mNAILΔNFκB mice. On DSS stimulation, infiltration of F4/80 cells 
increased in mNAILWT colons. Costaining of F4/80 and mNAIL 
showed that the infiltrated macrophages are the major source 
of mNAIL expression in DSS- treated colons (figure 6A–C- right- 
panel). Furthermore, only mNAIL expressing F4/80+ cells 
showed dramatic increase in p- p65 (figure 6A) and p- p38 (online 
supplemental figure 6A). Similar to our western blot analysis 
(figure 5H), we observed a dampened induction of p- p65 and 
p- p38 in the mNAILΔNFκB mice as compared with mNAILWT mice 
treated with DSS (figure 6A–C and online supplemental figure 
6B). Finally, H&E staining of the colon tissues suggested more 
severe pathology in mNAILWT mice compared with mNAILΔNFκB 
mice (online supplemental figure 6C,D). These results, together 
with our previous western blot analysis, suggest that mNAIL 
expression in colon- infiltrating macrophages regulates phos-
phorylation of p65 and p38 and hence inflammatory programme 
in these immune cells.
Indeed, the reduced infiltration of immune cells in mNAILΔNFκB 
mice, which was also observed in p38 myeloid specific KO 
mice,23 can be explained by the reduction in expression of CCL2 
gene (figure 5E), a key mediator of monocyte recruitment to the 
inflamed tissue.21 In line with our finding, in colitis model of 
p38 but not in p65 KO mice, it has been shown that expression 
of chemokines such as CCL2, CCL3 and CXCL10 was reduced 
as compared with WT mice which resulted in reduced infil-
tration of immune cells.23 25 CCR2–CCL2 dimerisation is very 
important for Ly6Chi cells in bone marrow which give rise to 
macrophages that are later recruited to inflamed area.27 Much 
like DSS- treated mNAILΔNFκB mice, the colitis model of p38 KO 
mice show reduced levels of Ly6Chi cells in bone marrow which 
results in less F4/80 infiltration to the colon.23
Importantly, our results showed that mNAIL is not induced 
in intestinal epithelial cells and there is no difference in 
TNFα expression between mNAILWT and mNAILΔNFκB mice 
(online supplemental figure 7A,B). These results showed that 
BMDMs are possibly the major source of mNAIL expression 
and phenotypes seen may stem from these cells, we performed 
bone marrow transplantation followed by DSS stimulation 
(figure 6D). We irradiated mNAILWT and mNAILΔNFκB mice 
and transplanted bone marrow cells isolated from mNAILWT or 
mNAILΔNFκB mice (figure 6D). mNAILWT or mNAILΔNFκB bone 
marrow reconstituted mNAILWT and mNAILΔNFκB animals were 
treated with DSS and body weight was measured for 8 days. As 
compared with mNAILWT bone- marrow transplanted mNAILWT 
group (blue), mNAILWT bone- marrow reconstituted mNAILΔNFκB 
mice (red) showed similar degree of body weight loss, reduction 
in colon length and expression of TNFα and IL1β (figure 6D–G). 
However, when compared with mNAILWT bone- marrow trans-
planted mNAILWT group (blue) or mNAILWT bone- marrow trans-
planted mNAILΔNFκB group (red), mNAILΔNFκB bone marrow 
reconstituted mNAILWT group (green) displayed lesser reduction 
in body- weight and colon length and showed lower expression 
of TNFα and IL1β (figure 6D–G).
Taken together, these results suggest that the differences in 
mNAILWT and mNAILΔNFκB mice in the DSS model stem from 
the immune cells, particularly from the infiltrated myeloid 
cells. These results also suggest that mNAILΔNFκB mice exhibit 
impaired NFκB and p38 activity leading to reduced inflamma-
tion in colon on DSS treatment. Reduced inflammatory cyto-
kines such as CCL2 in mNAILΔNFκB mice explain the reduced 
precursor cell population in bone marrow of these mice.28 
Reduction in inflammatory cytokines expression in mNAILΔNFκB 
mice may be attributed to reduced activation of p38 and p65, 
which are well- known upstream events that positively cooperate 
to regulate transcription of inflammatory genes in response to 
inflammatory stimuli.
NAIL sequesters Wip1 phosphatase away from its substrates 
p65 and p38
It has been previously shown that Wip1 phosphatase negatively 
regulates inflammatory gene expression by dephosphorylating 
p6529 and p38.30 Indeed, decreased activation of p65 and p38 
was seen in the absence of mNAIL (figures 4M and 5H). As 
numerous signalling pathways can be activated by TNFα stim-
ulation, we comprehensively analysed most immediate down-
stream pathways which are activated on TNF receptor ligation 
(online supplemental figure 7C). Based on the fact that p65 
and p38 phosphorylation were specifically affected in NAIL 
expressing cells, we hypothesised that Wip1 phosphatase, 
which affects these two substrates,31 might be a major effector 
of NAIL. Indeed, enzyme sequestration is a well- known regula-
tory mechanism on controlling cellular events.32–34 To test this, 
we checked Wip1- p65 interaction in colons of mNAILWT and 
mNAILΔNFκB mice treated with and without DSS and BMDMs 
treated with and without LPS. We found more Wip1 is bound to 
p65 in mNAILΔNFκB colon and BMDM cells even on stimulation 
and hence, p65 activation is defective (figure 7A,B and online 
supplemental figure 7D–F). We also found that in mNAILΔNFκB 
MEFs and BMDM cells, si- Wip1 rescued IL1β and TNFα expres-
sion and phosphorylation levels of p65 and p38 proteins, further 
suggesting that Wip1 is a key determinant of NAIL action (online 
supplemental figure 8). Taken together, these results suggest that 
NAIL can exert its function in trans by sequestering Wip1 phos-
phatase away from p65 or other Wip1 substrates like p38. It 
is possible that other substrates of Wip1 may also play a role 
in the described phenomenon consequent to the induction of 
NAIL. Given that this induction is dependent on the p65 subunit 
by copyright.
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Figure 5 mNAIL regulates expression of inflammatory genes in colitis. (A) Heat map shows the genes that are differentially expressed between 
mNAILWT and mNAILΔNFκB mice treated with DSS. Genes were first filtered for differential genes on DSS treatment between mNAILWT untreated 
(UT) and DSS to identify DSS- dependent genes. Next, this gene list was used to identify the differentially expressed genes between mNAILWT and 
mNAILΔNFκB mice treated with DSS. Differentially expressed genes were identified based on the criteria of 2 log2- fold difference with false discovery 
rate<0.05. (B–E) Expression analysis was performed by RT- qPCR for (B) mNAIL, (C) TNFα (D) IL1β and (E) CCL2 genes in the colon tissues of mNAILWT 
and mNAILΔNFκB mice treated with or without DSS at day 8 (n=15). (F–G) Protein levels of TNFα and IL1β cytokines were measured in colon samples 
by ELISA. Error bars indicate mean±SD of three independent experiments. P values were calculated using Student’s t- test method (**p<0.01; 
***p<0.001; ****p<0.0001). (H) Total protein lysates isolated from the colon tissues of mNAILWT and mNAILΔNFκB mice treated with or without DSS 
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Figure 6 mNAIL acts via immune cells to regulate inflammation. (A) Colon sections of the DSS- treated mNAILWT and mNAILΔNFκB mice at day 8 were 
stained with mNAIL specific FISH probe, F4/80 and p- p65 antibodies. Tissue slides were analysed for the indicated molecules by confocal microscopy. 
(B) Graph shows quantification of the number of F4/80+ cells from A. (C) Graph shows quantification of the number of F4/80+p- p65+cells from A. 
Error bars indicate mean±SD of three independent fields examined per mouse (n=3 per group). ***p<0.001; ****p<0.0001; n.s., not significant. P 
values were calculated by two- tailed Student’s t- test method. (D) mNAILWT or mNAILΔNFκB bone marrow reconstituted mNAILWT and mNAILΔNFκB mice 
were treated with DSS for 8 days. Graph shows the body weight measurements from mice monitored for 8 days (E) and the colon length at day 8. 
Graphs show gene expression analysis of (F) TNFα and (G) IL1β in the colon tissues of different bone marrow reconstituted groups treated with DSS 
for 8 days by qPCR. Data are normalised to actin. Error bars indicate mean±SD of two independent experiments (total n=12). P values were calculated 
using Student’s t- test method (***p<0.001; ****p<0.0001; n.s., not significant). DSS, dextran sulfate sodium; UT, untreated; WT, wild type.
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Figure 7 mNAIL sequesters Wip1 phosphatase away from its substrate in vivo. (A) Colon tissues were collected from mNAILWT and mNAILΔNFκB mice 
(n=4) treated with and without DSS for 8 days. (A) p65 protein was immunoprecipitated and coprecipitated proteins were analysed by western blot. 
Actin was used as a loading control. Each replicates are indicated as #1, #2, #3 and #4. (B) Graph shows quantification of coprecipitated Wip1 from 
A) (total n=4). Error bars indicate mean±SD of four replicates. P values were calculated using Student’s t- test method (**p<0.01; ***p<0.001). (C) 
Summary of phenotypes of p65, p38 myeloid specific knock mice, Wip1 null mice and mNAILΔNFκB in DSS model. Model based on our studies. (D) In the 
colitis model, in the presence of NAIL, activation of p38 and p65 is coordinated in a timely manner. On intestinal damage and release of microbiota to 
the colon, myeloid progenitor cells differentiate into immature myeloid cells which give rise to macrophages that infiltrate inflamed colon and express 
inflammatory genes. In the absence of NAIL, Wip1 prevents phosphorylation of p65 and p38 which leads to defects in generation of immature myeloid 
cells, reduction of recruitment of macrophages and deregulated expression of inflammatory genes. In the absence of TNFα or other inflammatory 
stimuli, Wip1 phosphatase is bound to p65 and its other targets such as p38. On activation of NFκB by TNFα, p65 is released from IκB proteins and 
p65 accumulates in the nucleus to activate target genes such as the NAIL lncRNA. Phosphorylation of p65 (p–p65) by a number of kinases mainly 
(IKKs) in the cytoplasm is critical for it to effectively bind to a subset of target genes, and subsequently, recruit p300 histone acetyltransferase for 
activating chromatin remodelling and for effectively kick- starting NFκB target gene expression. Meanwhile, NAIL lncRNA stimulated due to activation 
of p65 and squelches Wip1 phosphatase away from p65 or other Wip1 targets such as p38 thereby temporally regulating the kinetics of p65 and p38 
phosphorylation and hence activation of genes dependent downstream of these important pathways. In the absence of NAIL, p65 and other Wip1 
targets (p38) are avidly bound by Wip1 even after stimulation and this leads to reduced p- p65 and p- p38 levels and also reduced p300 recruitment to 
target genes along with lesser interaction of p38 and NFκB targets, resulting in decreased expression of the inflammatory genes. DSS, dextran sulfate 
sodium; UT, untreated; WT, wild type.
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of NFκB, NAIL could be the key factor required for full- blown 
inflammatory responses in an evolutionarily conserved fashion.
DISCUSSION
It is very well established that intestinal microbiota plays a key 
role in the development of UC. A multitude of regulatory check-
points, regulated mainly by NFκB and p38, collectively coordi-
nate the intensity and duration of the inflammatory response.35 36 
In normal conditions, mucosal immune system acts as an effec-
tive defence system against gut microbiota while maintaining 
the balance between proinflammatory and anti- inflammatory 
responses. This balance, in UC, is highly impaired and shifted 
towards hyperactive proinflammatory side, causing increased 
number of immune cells and high levels of cytokine secretion.3 
While the impact of NFκB and p38 on initiating inflammatory 
responses is well established, how the proinflammatory and anti- 
inflammatory responses are kept in balance is unclear. Hence, 
understanding how these signalling pathways are controlled is 
of great clinical value towards developing novel drug targets for 
therapeutic intervention in inflammatory diseases.
This study represents the first of its kind, where mouse genetic 
tools were used to identify novel lncRNAs that are directly and 
specifically regulated by NFκB signalling. We identified NAIL 
(anti- sense direction to IL7 gene) as the only evolutionarily 
conserved lncRNA across mice and humans. NAIL is specifically 
induced by inflammatory cytokines such as TNFα and TLR4 
ligand LPS in a p65- dependent fashion across cell types.
CRISPR- mediated deletion of NFκB binding motifs upstream 
of NAIL led to the loss of its expression and decreased inflam-
mation in vivo and in vitro. NAIL- deficient cells showed a reduc-
tion of p38 and p65- transactivation and subsequent decline in 
expression of key p38 and NFκB target genes. NFκB and p38 
have been shown to be required for the expression of proin-
flammatory and chemoattractant genes including Cxcl1, Cxcl2, 
TNFα and IL1β30 for full- blown inflammation. Most notably, 
loss of NAIL phenocopies p38 or p65 loss in vivo in DSS model 
as published by other laboratories23 25 37 (figure 7C). Our in vitro 
BMDM experiments (figure 4G–M) and in vivo DSS model 
clearly demonstrated that infiltrated macrophage cells are the 
major source of mNAIL expression and infiltration of F4/80+ 
cells are dampened in mNAILΔNFκB colons (figure 6A,B). Further-
more, only NAIL expressing F4/80+ cells showed dramatic 
increase in p- p65, suggesting that NAIL acts in mainly through 
immune cells for its mechanism of action (figure 6A–C). Indeed, 
bone marrow reconstitution experiment further proved this 
point as the DSS phenotype observed in mNAILΔNFκB mice was 
rescued on reconstitution of mNAILWT bone marrow into irra-
diated mNAILΔNFκB mice. Therefore, we can conclude that these 
phenotypic effects stem from the immune cells, particularly the 
infiltrated myeloid cells (figure 6D–G). Interestingly, unlike p38 
KO mice, p65 KO mice do not show defects in the infiltration of 
macrophage cells to the inflamed colon, which clearly highlights 
that simultaneous activation of both these pathways is critical for 
successful mounting of inflammation.
Our findings clearly explain that NAIL sequesters Wip1 away 
from p65 and p38 simultaneously to enable an orchestrated 
response that leads to (a) differentiation of precursor cells 
into immature myeloid cells in bone marrow, (b) recruitment 
of macrophages to inflamed area and (c) expression of inflam-
matory genes. Indeed contrary to NAIL, p65 or p38 null mice, 
Wip1 null animals show enhanced inflammation37 (figure 7C). 
As inflammatory responses and phenotypes observed in NAIL 
loss of function mice are inverse of what is seen in Wip1 KO 
mice and they phenocopy the combination of the phenotypes 
observed in p38 and p65 KO models, it is apparent that NAIL is 
the missing link that explains the coactivation of the two essen-
tial pathways, NFκB and p38, by Wip1 in inflammation.
In physiological conditions, regulation of inflammatory 
control includes multiple layers of responses. As in the example 
of DSS- induced colitis model, the first response is the damage 
in the epithelial barrier which evokes maturation and recruit-
ment signals in bone marrow.38 On sensing the damage signals 
and penetration of the microbiota to the colon, myeloid progen-
itor cells differentiate into immature myeloid cells which later 
on give rise to macrophages that are recruited to the inflamed 
areas in colon39 and express inflammatory genes (figure 7D). 
Indeed, p38 has been shown to regulate the differentiation of 
the myeloid progenitor cells into immature myeloid cells and 
later on via regulating the required chemoattractans that lead to 
infiltration of the macrophages into the inflamed colon.23 40 41 
In the next stage, on activation of NFκB pathway, these cells 
express the proinflammatory cytokines for full- blown inflam-
matory response.42 As these two important pathways, p38 and 
NFκB, have to be coactivated in a timely manner,43 NAIL acts as 
a bridge to coordinate the activity of these two essential path-
ways in colitis.
In chronic diseases such as IBD, immunosuppressive drugs are 
used to partially block NFκB activity.3 Finer dissection of the 
role of NAIL in chronic inflammatory diseases and cancer may 
present new insights to design better and more selective anti- 
inflammatory drugs. Such NAIL inhibitors could also be more 
efficacious since they simultaneously target both NFκB and 
p38 signalling. As compared with non- inflamed controls, NAIL 
expression is significantly enhanced in the inflamed colon tissues 
(figure 1G) suggesting that NAIL expression is highly correlated 
with NFκB activity and may serve as a biomarker and thera-
peutic target for IBDs and other diseases with inflammation as 
an underlying cause.
METHODS
BMDMs isolation and stimulation
BMDMs were isolated from femurs and tibias of sibling 
8–10- week- old mNAILWT and mNAILΔNFκB mice. Cells were 
plated on bacteriological plastic plates in DMEM with 30% 
L929 conditioned medium for 4 days. On day 4, remove non- 
attached cells and wash with prewarmed phosphate- buffered 
saline (PBS) and add fresh medium. On day 7, cells were disso-
ciated using 5 mM PBSethylenediaminetetraacetic acid (EDTA) 
and cell scraper. Differentiated BMDMs were stained by CD11b 
and F4/80 antibodies. Differentiated BMDMs were stimulated 
with LPS (200 ng/mL) for the indicated time points for protein 
isolation, RNA isolation and chromatin immunoprecipitation.
RNA-sequencing (RNA-seq) and analysis
Total RNA was isolated by using Trizol from immortalised 
WT and p65 and Ikkβ KO (-/-) MEFs that have been described 
previously.44 Cells were either stimulated with 10 ng/mL 
TNFα for 45 and 90 min or vehicle control. RNA- seq library 
was prepared by Illumina Truseq Total RNA sequencing kit 
according to manufacturer instructions. Paired- end sequencing 
was performed using Illumina Nextseq, 2×76 bp. Base quality 
assessment of raw sequence was performed using FastQC 
v0.11.8 and Trimmomatic v0.321 was used to filter low quality 
bases and adapter sequences. By using HISAT2 V.2.1, spliced 
alignment was performed on the quality trimmed sequences 
against Mus musculus (mm10) genome index which consist of 
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transcriptome splicing information. Stranded alignment (first- 
strand) was applied and the alignment was finally coordinate 
sorted using Samtools V.1.8. Gene- level expression counts were 
quantified (strand- specific read counting) using featureCounts 
(subread- V.1.6.2 package) by reference to the gene annotation 
obtained from Ensembl (V.96) database.
Differential genes expression analysis was performed by first 
removal of genes with very low reads count using filterByExp() 
function in edgeR V.3.26.4 package. Library sizes were recal-
culated after the filtering. Genes with fold change ≥ 2 and a 
false discovery rate (FDR)<0.05 were identified as significant 
differentially expressed genes (DEGs). Differentially expressed 
lncRNAs were extracted with reference to GENCODE lncRNA 
annotation of respective genomes.
RNA was isolated from the colon tissues of mNAILWT and 
mNAILΔNFκB mice treated with or without DSS. RNA- Seq library 
was prepared by Illumina Truseq Total RNA sequencing kit 
according to manufacturer instructions. Paired- end sequencing 
was performed using Illumina Hiseq, 2×150 bp. DEGs were 
identified by comparing DSS- treated mNAILΔNFκB versus 
DSS- treated mNAILWT and DSS- treated mNAILWT versus UT 
mNAILWT.
RNA sequencing data of UC patients were obtained from 
NCBI Sequence Read Archive (SRA), SRP125961 (GEO: 
GSE107593). Raw sequences were subjected to the same anal-
ysis process above and were aligned to Homo sapiens (GRCh38) 
genome index. DEGs were identified with the same threshold 
(fold change ≥ 2, FDR<0.05).
RNA isolation and real-time qPCR
Total RNA was extracted by Trizol and column purified using 
RNeasy Mini Kit for gene expression analysis. 1 µg RNA was 
used as a template for reverse transcription reaction using 
Maxima first- strand cDNA synthesis kit (Thermo Scientific). 
Then, real- time PCR was performed from diluted cDNAs using 
SsoAdvanced Universal SYBR Green Supermix (BioRad). Rela-
tive gene expression was analysed by ∆∆CT method by normal-
ising experimental Ct values to β-actin. Primers are indicated in 
the online supplemental table 1.
Western blot analysis
Total protein was extracted using Totex buffer (20 mM Hepes 
at pH 7.9, 0.35M NaCl, 20% glycerol, 1% NP-40, 1 mM 
MgCl2, 0.5 mM EDTA, 0.1 mM EGTA, 50 mM NaF and 0.3 mM 
NaVO3) supplemented with complete protease and phospha-
tase inhibitor cocktail (Roche). Immunoblotting was performed 
with following antibodies: anti- p- p38 (Thr180/Tyr182) 3D7 
(Cell signalling; #9215S), anti- p38 (Santa Cruz; #sc-728), anti- 
p- p65 (Ser536) (Cell signalling; #3031 L), anti- p65 (Santa Cruz; 
#sc-8008), anti- actin (Sigma; #A2066), anti- HSP90α/β (F-8) 
(Santa Cruz; #sc-13119), p- IKKα/β (Ser176/180) (Cell signal-
ling; #2697S), IKKα/β (H-470) (Santa Cruz; #7607) (online 
supplemental table 1).
ELISA analysis
Total protein was extracted from the colon tissues and TNFα 
and IL1β protein levels were quantified using Quantikine ELISA 
kit according to manufacturer’s instructions (Thermo Fisher 
Scientific).
Electrophoretic mobility shift assay
Electrophoretic mobility shift assay (EMSA) was performed 
as previously described.45 Briefly, 20 µg of total protein was 
incubated in reaction buffer (50% glycerol, 200 mM Hepes, pH 
7.9, 4 mM EDTA pH 8.0, 4 mM DTT), 2 µg polydI- dC, 1% NP40 
and [γ-32P] radiolabelled DNA probe for 30 min at room tempera-
ture. Samples were separated on 6% non- denaturing polyacryl-
amide gel, and the gel was dried and exposed to BAS- IP Image 
plate (Fuji) for scanning with Typhoon FLA 7000 (GE Health-
care). Radiolabelled probes: NF-κB:5′- TCAA CAGA GGGG 
ACTT TCCG AGAGGCC-3′, AP-1:5′- CGCT TGAT GACT CAGC 
GGGAA-3′.
Flow cytometry analysis
Bone marrow cells were isolated from mNAILWT and mNAILΔNFκB 
mice treated with and without DSS for 8 days. Cells were treated 
with ammonium- chloride- potassium (ACK) lysis buffer (Lonza) 
to eliminate red blood cells. Cells (~1×106 cells) were incubated 
with CD11b (PE), Ly6C (BV711) and Ly6G (FITC) fluorescence 
conjugated antibodies for 20 min at room temperature. To iden-
tify the stem cell populations, cells were stained with Lineage 
antibody cocktail (APC), c- KIT (PercpCy5.5), Sca-1 (FITC), 
CD34 (PE), IL7ra (PeCy7) and CD16/32 (APCcy7) (BD Biosci-
ences) After antibody incubation, cells were washed with PBS 
supplemented with 1% FBS and 2 mM EDTA and acquired using 
FACS LSR2 instrument (Becton Dickenson). Data were analysed 
using Flow Jo software.
Fluorescence in situ hybridisation
Custom Stellaris RNA FISH probes were designed against 
mNAIL by utilising the Stellaris RNA FISH Probe Designer 
(Biosearch Technologies, Petaluma, CA). FISH was performed 
using the mNAIL Stellaris FISH Probe set labelled with Quasar 
570, according to the manufacturer’s instructions available 
online at www. biosearchtech. com/ stellarisprotocols with slight 
modification. Briefly, colon tissues were sectioned at a thickness 
of 4 µm using a microtome and mounted onto a microscope 
slide. Tissue sections were immersed in 100% xylene for 10 min 
and an additional 5 min with fresh 100% xylene. Next, slides 
were immersed in 100% ethanol for 20 min followed by incuba-
tion in 95% ethanol for 10 min. Subsequently, antigen retrieval 
by citrate buffer was performed (slides were heated in a micro-
wave submersed in 1X citrate unmasking solution until boiling 
was initiated and kept for 20 min at a subboiling temperature 
(95°−98°C)). After allowing the slides to cool down on bench 
top for 20 min, slides were washed in dH2O three times for 5 min 
each and blocked with blocking solution (1% bovine serum 
albumin (BSA), 2% fetal bovine serum (FBS) in phosphate- 
buffered saline (PBS)) for 1 hour at room temperature. Subse-
quently, blocking solution was removed and Alexa Fluor 
647 antimouse F4/80 antibody (Clone:BM8, Cat# 123122, 
Biolegend) diluted in blocking solution and added onto slides for 
1 hour at room temperature. Slides were washed with 1X PBS 
three times for 5 min. Tissue sections were permeabilised in 70% 
ethanol for at least 1 hour at room temperature. After washing 
slides with 1X PBS twice for 2–5 min, slides were incubated with 
hybridisation buffer (SMF- HB1-10, Stelleris) containing NAIL 
probe (125 nM) and antibodies (1:1000 dilution, phospho- 
NF-κB p65 (Ser536) Rabbit mAb, Alexa Fluor 488 Conjugate, 
clone: 93H1, Cat#4886, CST or phospho- p38 MAPK (Thr180/
Tyr182) Rabbit mAb, Alexa Fluor 488 Conjugate, clone: 3D7, 
#41768, CST) in a humidified chamber (150 mm tissue culture 
plate sealed with parafilm; a single water- saturated paper towel 
placed alongside the inner chamber edge) for overnight in the 
dark at 37°C. After incubation, slides were immersed in Wash 
Buffer A (SMF- WA1-60, Stellaris) in the dark at 37°C for 30 min 
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to allow the submerged coverglass fall off from the slides. Finally, 
Wash Buffer A was removed, and 4′,6- diamidino-2- phenylindole 
(DAPI) was added to counterstain the nuclei and slides were 
covered with a coverglass for imaging by using ZEISS LSM800 
microscopy.
Chromatin immunoprecipitation
BMDM cells derived from mNAILWT and mNAILΔNFκB cells were 
stimulated with LPS (200 ng/mL) for 4 hours. Cells were cross-
linked on the plate with disuccinimidyl glutarate (DSG) (1.5 mM) 
(Thermo Fischer Scientific) for 30 min at room temperature 
with gentle shaking. After removing DSG, cells were fixed with 
1% formaldehyde for 10 min and the reaction was quenched 
with a final concentration of 0.125M glycine. After lysis, cell 
lysates were sonicated of an average size of 150–600 bp frag-
ments and precleared with Protein A/G sepharose beads for 
1 hour. After centrifugation, 2% input was stored as an input. 
Lysates (~4 million cells) were incubated with 4 µg p65 (Santa- 
Cruz, sc-372) antibody overnight at 4°C on a rotator. Immune 
complexes were immunoprecipitated with protein A/G sepharose 
beads and samples were eluted in a final volume of 60 µL after 
reverse crosslinking overnight. ChIP- qPCR was performed using 
TNFα and CXCL2 promoter- specific primers. Enrichment was 
calculated by % input method.
Immunoprecipitation assay
Cells were harvested and lysed in IP lysis buffer [50 mM Tris- HCl 
pH 8.0, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 
0.1% sodium dodecyl sulfate (SDS)]. Protein concentration 
was measured by Bradford method. p65 was immunoprecipi-
tated after incubating cell lysate with p65 antibody for 6 hours 
and an additional 2 hours with Protein G Sepharose beads (GE 
Healthcare). The beads were washed three times with washing 
buffer (10 mM Tris- HCl pH 7.5, 1 mM EDTA, 1 mM ethylene 
glycol- bis(β-aminoethyl ether)- N,N,N′,N′-tetraacetic acid 
(EGTA), 150 mM NaCl, 1% Triton X-100) and immunoprecip-
itated proteins were eluted by boiling the beads in 2X loading 
sample buffer (LDS) (Invitrogen) for 10 min. Immunoblotting 
was performed as described above with the following antibodies: 
anti- Wip1 antibody (1:1000 Cell signalling; #11901), anti- p65 
antibody (1:1000, Santa Cruz; sc-8008).
Generation of mice
We designed crRNAs targeting 5′- TAGGGTTTAAAAGCG-
CATCC-3′ and 5′- AGTCTGGGAGTTTCCGATCC-3′ in the 
5′UTR of Gm16685, then generated NAILΔNFκB mice by intro-
ducing the CAS9/tracrRNA/crRNAs complex into the oocytes 
with electroporation, as described previously.46 In brief, CARD 
HyperOva (0.1 mL, Kyudo, Tosu, Saga, Japan) was injected 
into the abdominal cavity of C57BL/6N females [Japan SLC 
(Hamamatsu, Shizuoka, Japan)] followed by human chorionic 
gonadotropin (hCG) (five units, ASKA Pharmaceutical). After 
14 hours of hCG injection, the oocytes were collected from the 
ampulla of the oviduct and then were used for in vitro fertil-
isation.47 The fertilised eggs were electroporated with the 
CAS9/tracrRNA/crRNA ribonucleoprotein complex, and then 
transplanted into the ampulla of the oviduct of pseudopreg-
nant females. After 19 days, offspring were obtained by natural 
birth or Caesarean section. We genotyped the offspring by PCR 
with KOD- Fx neo (TOYOBO, Osaka, Japan) and a primer set 
(Fw: 5′- TTAGATTTGATCAGGGAGC-3′, Rv: 5′- TCAGTG-
GTTTTCAGCCACTT-3′) and direct sequencing. The PCR 
condition was 94°C for 3 min, denaturing at 94°C for 30 s, 
annealing at 55°C for 30 s, elongation 72°C for 30 s for 40 cycles 
total, followed by 72°C for 2 min. Briefly, we obtained 22 pups 
from 89 treated zygotes and seven out of 12 analysed pups 
carried the 80 or 82 bp deletion. We crossed these mice to WT 
animals for two generations to purify 80 bp deletion mutants 
and also decrease the risks of off- target cleavage. Then heterozy-
gous mutants were crossed to obtain homozygous 80 bp deletion 
mutant mice which was confirmed by Sanger sequencing. Subse-
quently, KO mouse was crossed back to WT to obtain heterozy-
gous animals which were used as breeders to generate littermate 
WT, HT and KO groups for experiments.
Animal studies and ethical requirements
DSS model was conducted as previously described.48 Briefly, 
mNAILWT and mNAILΔNFκB mice were fed with 3% DSS in 
drinking water for 4 days and replaced with normal water for 
another 4 days. Body weight was measured daily and mice were 
sacrificed at day 8. Colon (distal) and bone marrow tissues were 
harvested and used for downstream analysis including RNA, 
protein and flow cytometry analysis. Intestinal epithelial cells 
were isolated for gene expression analysis from the colon tissues 
as reported previously.49 DAI was assessed by using the evalua-
tion system: (i) body weight loss (no weight loss was scored as 
0 points, weight loss of 1%–5% as one point, 5%–10% as two 
points, 10%–20% as three points and more than 20% as four 
points);50 stool consistency (0 point was given for well- formed 
pellets, two points for pasty and semiformed stools that did not 
stick to the anus and four points for liquid stools that remained 
adhesive to the anus). For histological scoring, the sections were 
graded in a blind manner by two independent investigators with 
a range from 0 to 3 for the amount of inflammation, depth of 
inflammation and with a range from 0 to 4 for the amount of 
crypt damage. For bone marrow transplantation, single cell 
suspension of bone marrow cells was obtained from the tibia 
and femur of mNAILWT and mNAILΔNFκB 8–10 weeks old (male) 
donor mice. 3×106 bone marrow cells were injected via the tail 
vein into mNAILWT and mNAILΔNFκB lethally irradiated (9.5 
Grey) 8–10 weeks old recipient (male) mice. Two weeks’ post- 
transplantation, the mice were placed on the DSS- induced colitis 
model.
All animal studies were conducted in accordance with the 
Institutional Animal Care and Use Committee at A*STAR (Singa-
pore). All procedures were approved under the IACUC protocol 
ID # 181 396.
Statistical analysis
Two- tailed Student’s t- test was performed for statistical analysis 
of between two groups. PRISM software V.7 was used to plot 
graphs and for statistical analysis.
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Sup. Figure 1: Validation of NFκB KO MEF cells. A) Western blot analysis of p65-/-, Ikkβ-/- 
and Ikkγ-/- immortalized MEFs with indicated antibodies. B) EMSA was performed using either 
NFκB or AP1 consensus sequence radiolabelled probes as indicated using protein extracts from 
WT, p65-/-, Ikkβ-/- and Ikkγ-/- immortalized MEFs treated with TNFα for the indicated time 
points. C) RNA-seq analysis of Gm16685 expression in WT, p65-/-and Ikkβ-/- immortalized 
MEFs exposed to TNFα for indicated duration. D) RT-qPCR analysis of Gm16685 expression 
in WT, p65-/-, Ikkβ-/- and Ikkγ-/-immortalized MEFs exposed to TNFα for indicated duration. E) 
RT-qPCR analysis of Gm16685 expression in immortalized WT MEFs exposed to LPS 
(100ng/ml) for indicated time points. F) RT-qPCR analysis of IL7 expression in WT, p65-/-, 
IKKβ-/- and IKKγ-/- immortalized MEFs exposed to TNFα for indicated time points. Error bars 
indicate mean ± SD of three independent experiments. P values were calculated using Student's 
t-test method (**, p<0.01; ***, p<0.001). 
 
 
 Sup. Figure 2: Conservation and analysis of Gm16685 lncRNA. A) Multiple sequence 
alignment using promoter sequence of the mouse Gm16685 and sequence of 31 other species 
at the same region with reference to UCSC comparative genomic track. Clustal Omega was 
used for the alignment. B) Promoter motifs enrichment analysis by using Homer-v4.1.0 
package. Top 10 most enriched motifs are shown. C) Prediction of different RBPs that can bind 
to Gm16685 or loc105375914 was performed using RBPmap server 
(http://rbpmap.technion.ac.il/). Venn diagram representing numbers of overlapping predicted 
RBPs that can bind both Gm16685 and loc105375914 is shown. D) ChIP-seq analysis of p65 
(RelA) binding in mouse dendritic and macrophage cells exposed to LPS for 2 hours based on 
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published data (GSE36099 and GSE93736 or GSE93602). E) ChIP-seq analysis of RelA and 
Pol2 signal in human adipocyte and IMR90 fibroblasts exposed to TNFα for 1hour based on 
published data (GSE60462 and GSE43070). F) Bar plot shows the coding probability of seven 
NAIL (Loc105375914 for human and Gm16685 for mouse) transcript sequences (six hNAIL 
isoforms and one mNAIL) together with a known lncRNA sequence, TERC and actin gamma 
1 (ACTG1) mRNA sequence as positive and negative control. Coding probability was 
calculated with CPC2 tools which indicate the closeness to the coding classification hyper-
plane in the trained support vector machine (SVM) model. G) 293T cells were transfected with 
Flag, NAIL-Flag and PKR-Flag (Protein kinase R) vectors. Total cell lysates were resolved in 
SDS-PAGE gel and immunoblotted for Flag and Hsp90 proteins. 
 
Sup. Figure 3: No difference in IL-7 expression and induction in mNAILΔNFκB mice. A) 
Gene expression profiles of mouse IL7 across different mouse tissues. All the raw FPKM 
values were obtained from Mouse ENCODE transcriptome data in NCBI (BioProject: 
PRJNA66167, Publication: PMID 25409824). B) Gene expression analysis was performed by 
RT-qPCR for mouse IL7 in the thymus tissues of mNAILWT and mNAILΔNFκB mice (n=3). C) 
Total protein lysates isolated from the thymus tissues of mNAILWT and mNAILΔNFκB mice were 
analysed for mouse IL7 by western blot. Actin was used for normalization. Graph shows the 
quantification of IL7 western blot band intensity. D-F) Wild-type MEFs were transfected with 
si-Control, mouse IL7 siRNA#1 or mouse IL7 siRNA#2. After 48h post-transfection, cells 
were treated with or without TNFα and harvested for gene expression analysis or western blot. 
Graphs show the gene expression analysis of D) IL7 and E) TNFα by RT-qPCR. Actin was 
used as a control. Error bars indicate mean ± SD of three independent experiments. P values 
were calculated using Student's t-test method (*, p<0.05; **, p<0.01; ***, p<0.001; ****, 
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p<0.0001; n.s., not significant). F) Cells lysate were analysed via western blot for the indicated 
proteins. 
 
Sup. Figure 4: No difference in stem cells and precursor cells between mNAILWT and 
mNAIL
ΔNFκB mice. A-E) Bone marrow cells were isolated from mNAILWT and mNAILΔNFκB 
mice (n=7) and treated with or without DSS at day 8. Cells were stained for Lineage marker 
cocktail, CD34, IL7ra, c-KIT, Sca-1 and CD16/32 cell surface markers. A) Cells were analysed 
by FACS and firstly gated as LIN- cells.  LIN- cells were further gated as KL, KSL and K-low 
S-low cells based on the c-KIT and Sca-1 expression.  KL cells were further gated into MEP, 
CMP and GMP according to CD16/32 and CD34 expression. K-low and S-low cells were gated 
for CLP population based on the IL7ra expression. Representative FACS data was shown for 
mNAILWT and mNAILΔNFκB mice treated with or without DSS. Quantification of B) GMP, C) 
CMP, D) MEP and E) CLP cells. Error bars indicate mean ± SD of 3 UT and 7 DSS treated 
samples. P values were calculated using Student's t-test method (n.s., not significant). 
Sup. Figure 5: Genome editing process did not cause non-specific global transcriptome 
changes. A) RNA-seq was performed with colon tissues obtained at Day 8 from mNAILWT and 
mNAILΔNFκB mice treated with or without DSS. Venn diagram representing numbers of 
overlapping differentially expressed genes between different experimental groups is shown. B) 
GO analysis was performed from the genes that are differentially expressed between mNAILWT 
and mNAILΔNFκB mice treated with DSS.   
Sup. Figure 6: mNAILΔNFκB mice are protected from DSS induced colitis. A, B) Colon 
sections of the DSS treated mNAILWT and mNAILΔNFκB mice (n=3) at day 8 were stained with 
mNAIL specific FISH probe (Quasar570), F4/80 (AF647) and p-p38 (AF488) antibodies. 
Tissue slides were analysed for the indicated molecules by LSM800 confocal microscopy. 
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Nuclei were counterstained with DAPI. Representative images for co-staining of A) mNAIL, 
F4/80 and p-p38 is shown. Quantification of B) F4/80, mNAIL and p-p38 positive cells is shown 
as bar graphs. Error bars indicate mean ± SD of three independent fields examined per mouse 
(n=3 per group). *, p < 0.05; ****, p < 0.0001. p-values were calculated by two-tailed student’s 
t-test method based on three independent experiments. C) Representative H & E staining and 
D) quantification of histology scores of colon sections from DSS treated mNAILWT and 
mNAILΔNFκB mice at day 8. Error bars indicate mean ± SD of three independent experiments 
(n=9 for UT, n=15 for DSS treated samples) 
Sup. Figure 7: NAIL alters phosphorylation of p65 and p38 but not upstream molecules. 
A-B) Graphs show the gene expression analysis of A) mNAIL and B) TNFα by RT-qPCR in 
intestinal epithelial cells isolated from colon tissues of mNAILWT and mNAILΔNFκB mice treated 
with and without DSS for 8 days. Actin was used as a control. Error bars indicate mean ± SD 
of 6 mice. P values were calculated using Student's t-test method (**, p<0.01; ***, p<0.001). 
n.s., not significant.  C) mNAILWT MEFs were transfected with si-Control or si-NAIL and after 
48h post-transfection, cells were stimulated with TNFα for indicated time points. Cell lysates 
were analyzed by western blot for the indicated proteins. D-E) Bone marrow cells isolated from 
mNAILWT and mNAILΔNFκB mice (n=4) were differentiated into bone marrow derived 
macrophages (BMDM) for 7 days. BMDM cells were treated with or without LPS (200ng/ml) 
for 4 hours. p65 immunoprecipitation was performed. Total and co-immunoprecipitated 
proteins were resolved on SDS-PAGE and immunoblotted for indicated proteins. F) Graph 
shows quantification of co-precipitated Wip1 from D-E. Error bars indicate mean ± SD of four 
replicates. P values were calculated using Student's t-test method (**, p<0.01). 
Sup. Figure 8: Wip1 is a key determinant of NAIL action. A-C) mNAILWT and mNAILΔNFκB 
MEFs were transfected with control siRNA or Wip1 siRNA. After 48h post-transfection, cells 
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were treated with or without TNFα and harvested for gene expression analysis or western blot. 
Graphs show the gene expression analysis of A) IL1β and B) TNFα by RT-qPCR. Actin was 
used as a control. C) siRNA transfected and TNFα stimulated MEFs cell lysates were analysed 
via western blot for the indicated proteins. D-F) mNAILWT and mNAILΔNFκB BMDMs were 
transfected with control siRNA or Wip1 siRNA. After 48h post-transfection, cells were treated 
with or without LPS and harvested for gene expression analysis or western blot. Graphs show 
the gene expression analysis of D) IL1β and E) TNFα by RT-qPCR. Actin was used as a control. 
Error bars indicate mean ± SD of three independent experiments. P values were calculated 
using Student's t-test method (***, p<0.001). F) siRNA transfected and LPS stimulated 
BMDM cell lysates were analysed via western blot for the indicated proteins.  
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Sup-Table 1 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
anti-p-p38 (Thr180/Tyr182) 3D7  Cell signalling Cat #9215S 
anti-p38  Cell signalling Cat #9212 
anti-p-p65 (Ser536)  Cell signalling Cat #3031L 
anti-p65  Santa Cruz Cat #sc-8008 
anti-Actin  Sigma Cat #A2066 
GAPDH (6C5) Santa Cruz Cat #sc-32233 
p-IKKα/β (Ser176/180)  Cell signalling Cat #2697S 
IKKα/β (H-470)  Santa Cruz Cat #sc-7607 
IKKγ (FL-419) Santa Cruz Cat #sc-8330 
anti-p65 (ChIP, IP) Santa Cruz Cat #sc-372 
anti-Wip1 (RIP) Cell signalling Cat #11901 
anti-Wip1(WB) Santa Cruz Cat # sc-376257 
Dyskerin (H-300) Santa Cruz Cat #sc-48794 
anti-IL7 R&Dsystems Cat # AF407 
P-SEK1/MKK4(T261) Cell signalling Cat # 9151S 
anti-SEK1/MKK4 Cell signalling Cat # 9152S 
p-TAK1 (T187) Cell signalling Cat # 4536S 
p-IkBα (S32) Cell signalling Cat # 2859L 
p-SAPK/JNK (Thr183/Tyr185) Cell signalling Cat # 9251 
anti-P-MKK3/MKK6 (Ser189/207) Cell signalling Cat # 9231 
anti-Cleaved Caspase-3 (Asp175) Cell signalling Cat #9664L 
PE-CD11b BD Cat #553311 
FITC-Ly6G Biolegend Cat #127606 
BV711-Ly6C Biolegend Cat #128037 
PE-CD34 BD Cat #551387 
PeCy7-IL7RA BD Cat #560733 
PercpCy5.5-c-kit BD Cat #560557 
FITC-Sca1/Anti-Ly-6A/E BD Cat #553335 
APCcy7-CD16/32 BD Cat #560541 
APC Mouse Lineage Antibody Cocktail BD Cat #558074 
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AF488-p-NF-κB p65 (Ser536) (93H1) CST Cat #4886 
AF488-p -p38 MAPK (Thr180/Tyr182) (3D7) CST Cat #41768 
Chemicals, recombinants proteins, 
commercial kits 
Recombinant Human TNF-alpha Protein 210 R&Dsystems Cat #210-TA 
Terminal deoxynucleotidyltransferase  Promega Cat #M1871 
RQ1 RNase-Free DNase  Promega Cat #M6101 
Recombinant RNasin ribonuclease inhibitor Promega Cat #N2111 
T7 RNA polymerase  Promega Cat #P2075 
10X Biotin RNA labelling mix  Roche Cat #11685597910 
Tak1 inhibitor 5Z-7-Oxozeaenol Sigma Cat #O9890-1MG 
E. coli LPS  Sigma Cat #L2654 and #L2630 
Dextran sulfate sodium salt, colitis grade MP Biomedicals Cat # 9011-18-1 
Disuccinimidyl glutarate (DSG)  Thermoe Fisher Cat #20593 
X-tremeGENE 9 DNA transfection reagent Roche Cat #6365779001 
X-tremeGENE siRNA transfection reagent Roche Cat #4476093001 
Experimental Models: Organisms/Strains 
Mouse: wild-type: C57BL/6  Invivos N/A 
Mouse: wild type Balb/c Invivos N/A 
Mouse: mNAIL∆NFκB Masa’s group This study 











RT‐qPCR_mTNFa Rv (GAAGCCCCCCATCTTTTGG)  IDT N/A 
RT‐qPCR_mIL7 Fw (TGGAATTCCTCCACTGATCC)  IDT N/A 
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Gm16685 gRNA #1 
(CACCTAGGGTTTAAAAGCGCATCC)  
IDT N/A 












Mouse  IL7 transcript variant 4 siRNA#1 
(AGCTCAGAACTTCATGGAGAATGAA) 
IDT N/A 
Mouse  IL7 transcript variant 4 siRNA#1 
(AAAGGACAGAUCAUUGGAAAACCCC) 
IDT N/A 
Mouse  IL7 siRNA#1 
(GACAGGAACTGATAGTAAT) 
IDT N/A 




pX458 –GFP   Addgene Cat #48138 
pX458-DsRed  Akincilar et al., 2016 N/A 
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